Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FFZVR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
OMTX-503
|
|||||
| Synonyms |
OMTX 503; OMTX503
Click to Show/Hide
|
|||||
| Organization |
Oncomatryx Biopharma SL
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Ewing sarcoma [ICD11:2B52]
Investigative
|
|||||
| Antibody Name |
OMTX003
|
Antibody Info | ||||
| Antigen Name |
Endoglin (ENG)
|
Antigen Info | ||||
| Payload Name |
Nigrin b
|
Payload Info | ||||
| Therapeutic Target |
Ribosome (RB)
|
Target Info | ||||
| Linker Name |
Succynimidyloxycarbonyl-alpha-methyl-alpha-(2-pyridyl-dithio) toluene (SMPT)
|
Linker Info | ||||
| Conjugate Type |
ADC were generated by cystein-based conjugation of OMTX003 to either the ribosome-inactivating protein nigrin-b A chain (OMTX503).
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.